Alimera Sciences (ALIM) director Kong received 6,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Garheng Kong (director at Alimera Sciences Inc., ALIM) reported that they received 6,000 Stock Option (Right to Buy) on Jan 4, 2023.
- Reporting person
- Kong Garheng
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 4, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 6,000 Common Stock1 | +6,000 | - | - | 6,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 6,000 direct
Footnotes from the filing
- 1. Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Kong report in this ALIM Form 4?
Garheng Kong (director at Alimera Sciences Inc., ALIM) reported that they received 6,000 Stock Option (Right to Buy) on Jan 4, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALIM
Earlier insider filings at ALIM
- Jan 6, 2023SEC Form 4 filed by Pizzo Peter J. Iii
- Nov 2, 2022SEC Form 4: Jones John Philip was granted 372 shares, increasing direct ownership by 1% to 32,185 units
- Nov 2, 2022SEC Form 4: Holland David was granted 500 shares, increasing direct ownership by 1% to 40,880 units
- Nov 2, 2022SEC Form 4: Eiswirth Richard S Jr was granted 500 shares, increasing direct ownership by 0.37% to 136,518 units
- May 3, 2022SEC Form 4: Eiswirth Richard S Jr was granted 500 shares, increasing direct ownership by 0.37% to 136,018 units
Quantisnow market dataNASDAQ
ALIM
Alimera Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2010
Get push alerts for ALIM
Full ALIM profile on Quantisnow Follow ALIM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time